Anti-tumor activity of biodegradable polymer-paclitaxel conjugate micelles on lewis lung cancer mice models

Journal of Biomaterials Science, Polymer Edition

Volumn 22, Issue 9, 2011, Pages 1131-1146

  Wan, Yanhui ^a   Zheng, Yonghui ^b   Song, Xiangfu ^a   Hu, Xiuli ^b   Liu, Shi ^b   Tong, Ti ^a   Jing, Xiabin ^b  

^a JILIN UNIVERSITY   (China)

^b CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

cell apoptosis; folic acid; Lewis lung cancer; paclitaxel; polymer drug conjugate; targeted drug delivery

Indexed keywords

BIODEGRADABLE POLYMERS; BIOLOGICAL ORGANS; CELL DEATH; CONTROLLED DRUG DELIVERY; DISEASES; ETHYLENE GLYCOL; MAMMALS; MICELLES; MOLECULAR BIOLOGY; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; POLYOLS; TUMORS;

CELL APOPTOSIS; FOLIC ACIDS; LUNG CANCER; PACLITAXEL; POLYMER DRUGS;

TARGETED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; FOLIC ACID; MACROGOL; PACLITAXEL; PACLITAXEL POLY(ETHYLENEGLYCOL) BLOCK POLY(LACTIDE CO 2 METHYL 2 CARBOXYLPROPYLENE CARBONATE) CONJUGATE; PACLITAXEL POLY(ETHYLENEGLYCOL) BLOCK POLY(LACTIDE CO 2,2 DIHYDROXYMETHYLPROPYLENE CARBONATE) FOLIC ACID CONJUGATE; POLYMER; PROPYLENE CARBONATE; UNCLASSIFIED DRUG; DRUG CARRIER; MICELLE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIODEGRADABILITY; CANCER INHIBITION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; ENDOCYTOSIS; FLOW CYTOMETRY; LEWIS CARCINOMA; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CARCINOMA, LEWIS LUNG; CHEMISTRY; DRUG EFFECTS; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; PATHOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE; TUMOR VOLUME;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; DRUG CARRIERS; FEMALE; FOLIC ACID; INJECTIONS, INTRAVENOUS; MICE, INBRED C57BL; MICELLES; NANOPARTICLES; NEOPLASM TRANSPLANTATION; PACLITAXEL; POLYMERS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 79952162894     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/092050610X500570     Document Type: Article

References (36)

1. H. Jiang, Jpn. J. Clin. Oncol. 39, 137 (2009).
2. P. Crosasso, M. Ceruti, P. Brusa, S. Arpicco, F. Dosio and L. Cattel, J. Control. Rel. 63, 19 (2000)
3. J.-q. Kong, W. Wang, P. Zhu and K.-d. Cheng, Yaoxue Xuebao 42, 358 (2007).
4. E. K. Rowinsky and R. C Donehower, New Engl. J. Med. 332, 1004 (1995).
5. R. B. Weiss, R. C Donehower, P. H. Wiernik, T. Ohnuma, R. J. Gralla, D. L. Trump, J. R. Baker, D. A. Vanecho, D. D. Vonhoff and B. Leyland-Jones, J. Clin. Oncol. 8, 1263 (1990).
6. S. A. Jenekhe and X. L. Chen, Science 279, 1903 (1998).
7. A. Rosler, G. W. M. Vandermeulen and H. A. Klok, Adv. Drug Deliv. Rev. 53, 95 (2001).
8. M. L. Adams, A. Lavasanifar and G. S. Kwon, J. Pharm. Sci. 92, 1343 (2003).
9. G. Gaucher, M. H. Dufresne, V. P. Sant, N. Kang, D. Maysinger and J. C Leroux, J. Control. Rel. 109, 169 (2005).
10. R. G. Schoenmakers, P. van de Wetering, D. L. Elbert and J. A. Hubbell, J. Control. Rel. 95, 291 (2004).
11. Z. Xie, H. Guan, X. Chen, C Lu, L. Chen, X. Hu, Q. Shi and X. Jing, J. Control. Rel. 117, 210 (2007).
12. K. Ulbrich and V. Subr, Adv. Drug Deliv. Rev. 56, 1023 (2004).
13. E. R. Gillies, A. P. Goodwin and J. M. J. Frechet, Bioconjug. Chem. 15, 1254 (2004).
14. V. S. Trubetskoy and V. P. Torchilin, Adv. Drug Deliv. Rev. 16, 311 (1995).
15. N. Nishiyama and K. Kataoka, Curr. State Pharmacol. Ther. 112, 630 (2006).
16. D. Kim, Z. G. Gao, E. S. Lee and Y. H. Bae, Mol. Pharm. 6, 1353 (2009).
17. Y. Bae, N. Nishiyama and K. Kataoka, Bioconjug. Chem. 18, 1131 (2007).
18. M. Sirova, J. Strohalm, V. Subr, D. Plocova, P. Rossmann, T. Mrkvan, K. Ulbrich and B. Rihova, Cancer Immunol. Immunother. 56, 35 (2007).
19. J. W. Hopewell, R. Duncan, D. Wilding and K. Chakrabarti, Human Exp. Toxicol. 20, 461 (2001).
20. H. S. Yoo and T. G. Park, J. Control. Rel. 96, 273 (2004).
21. K. Ulbrich, T. Etrych, P. Chytil, M. Jelinkova and B. Rihova, J. Drug Target. 12, 477 (2004).
22. Y J. Lu and P. S. Low, Adv. Drug Deliv. Rev. 54, 675 (2002).
23. J. Sudimack and R. J. Lee, Adv. Drug Deliv. Rev. 41, 147 (2000).
24. C Deng, X. Chen, H. Yu, J. Sun, T. Lu and X. Jing, Polymer 48, 139 (2007).
25. C Deng, G. Rong, H. Tian, Z. Tang, X. Chen and X. Jing, Polymer 46, 653 (2005).
26. C Deng, H. Tian, P. Zhang, J. Sun, X. Chen and X. Jing, Biomacromolecules 7, 590 (2006).
27. T. Lu, J. Sun, X. Chen, P. Zhang and X. Jing, Macromol. Biosci. 9, 1059 (2009).
28. Z. Xie, X. Hu, X. Chen, T. Lu, S. Liu and X. Jing, J. Appl. Polym. Sci. 110, 2961 (2008).
29. Z. Xie, T. Lu, X. Chen, C Lu, Y. Zheng and X. Jing, J. Appl. Polym. Sci. 105, 2271 (2007).
30. X. Zhang, Y. Li, X. Chen, X. Wang, X. Xu, Q. Liang, J. Hu and X. Jing, Biomaterials 26, 2121 (2005).
31. X. Hu, S. Liu, X. Chen, G. Mo, Z. Xie and X. Jing, Biomacromolecules 9, 553 (2008).
32. Z. Xie, H. Guan, L. Chen, H. Tian, X. Chen and X. Jing, Polymer 46, 10523 (2005).
33. H. F. Liu, W. W. Liu and D. C Fang, World Chin. J. Digestol. 8, 1361 (2000).
34. A. Y. Chang, J. Rubins, R. Asbury, L. Boros and L. F. Hui, Semin. Oncol. 28, 10 (2001).
35. R. T. Allen, W. J. Hunter and D. K. Agrawal, J. Pharmacol. Toxicol. Methods 37, 215 (1997).
36. J. P. Aubry, H. Blaecke, S. Lecoanet-Henchoz, P. Jeannin, N. Herbault, G. Caron, V. Moine and J. Y. Bonnefoy, Cytometry 37, 197 (1999).